MiNK Therapeutics Dr. Jennifer Buell to Deliver Featured Plenary at 10th Annual CAR-TCR Summit in Boston, MA

Benzinga
2025.09.25 12:37
portai
I'm PortAI, I can summarize articles.

NEW YORK, Sept. 25, 2025 ( GLOBE NEWSWIRE ) -- MiNK Therapeutics, Inc. ( NASDAQ: INKT ) , a clinical-stage biopharmaceutical company pioneering invariant natural killer T ( iNKT ) cell therapies, today announced that its President and Chief Executive Officer, Dr. Jennifer Buell, will deliver a ...

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2026 Longbridge｜Disclaimer